Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002002390-26-000005
Filing Date
2026-03-18
Accepted
2026-03-18 14:23:32
Documents
3
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 7649
2 EX-24.POA phvs-ex24_poa.htm EX-24.POA 16942
3 GRAPHIC img151619395_0.gif GRAPHIC 10427
  Complete submission text file 0002002390-26-000005.txt   40704
Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands 31 (0)71 203 6410
Pharvaris N.V. (Issuer) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PHARVARIS N.V. EMMY NOETHERWEG 2 LEIDEN P7 2333 BK
Business Address
Abele Stefan Andreas (Reporting) CIK: 0002002390 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40010 | Film No.: 26768006